Last update 21 Nov 2024

Allogeneic anti-IL3RA｜NKG2D CAR-T (Tianjin First Center Hospital)

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms-
Target
CD123 x NKG2D
Mechanism
CD123 inhibitors(Interleukin-3 receptor subunit alpha inhibitors), NKG2D antagonists(NKG2-D type II integral membrane protein antagonists)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
Acute Myeloid Leukemia
Inactive Indication-
Originator Organization
Tianjin First Center HospitalTianjin First Center Hospital
Active Organization
Tianjin First Center HospitalTianjin First Center Hospital
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Allogeneic anti-IL3RA｜NKG2D CAR-T (Tianjin First Center Hospital)
ChiCTR1900022058 / SuspendedEarly Phase 1IIT
CD123 chimeric antigen receptor T cells (CART) therapy for relapse or refractory Blastic plasmacytoid dendritic cell neoplasm
ChiCTR1800020083 / RecruitingPhase 1IIT
Donor-derived Anti-CD123-CART Cells for relapse AML After Allo-HSCT
ChiCTR1800017843 / RecruitingIIT
A Clinical Research of CD123-Targeted CAR-T in CD123 positive refractory or relapsed Myeloid leukemia
100 Clinical Results associated with Allogeneic anti-IL3RA｜NKG2D CAR-T (Tianjin First Center Hospital)
Login to view more data
100 Translational Medicine associated with Allogeneic anti-IL3RA｜NKG2D CAR-T (Tianjin First Center Hospital)
Login to view more data
100 Patents (Medical) associated with Allogeneic anti-IL3RA｜NKG2D CAR-T (Tianjin First Center Hospital)
Login to view more data
100 Deals associated with Allogeneic anti-IL3RA｜NKG2D CAR-T (Tianjin First Center Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 1-
Tianjin First Center HospitalTianjin First Center Hospital
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free